Launch Date
11/30/2023
Credit Amount
0.5
Credit Expires
11/30/2024
Shared decision-making (SDM) is a collaborative effort between patients and clinicians to share evidence and consider options regarding health care decisions. SDM is a significant facet of chronic kidney disease (CKD) care and is especially relevant for anemia in CKD, wherein treatment options carry uncertainty and variability. Patients, however, lack knowledge of anemia in CKD; many patients are not aware of their hemoglobin levels or recognize that their anemia and kidney disease are linked, and only half understand different treatment options. It is imperative that clinicians are appraised of how to educate CKD patients with anemia and facilitate informed care decisions, especially in the sensitive contexts of life experience and culture for underserved and rural populations.
In the third activity of this CME Outfitters BriefCase series, expert faculty utilize case-based learning to guide learners on integration of SDM principles to ensure that patient needs and preferences are aligned with anemia and CKD treatment plans.
Integrate SDM principles to ensure that patient needs and preferences are aligned with anemia and CKD treatment plans.
This educational activity is supported by an educational grant from GSK.
Physicians, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists specializing in nephrology or primary care
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Spinowitz reports the following financial relationships:
Advisory Board: Akebia Therapeutics, Inc.; AstraZeneca; GSK; and Renibus Therapeutics
Research Support: AstraZeneca and Travere Therapeutics, Inc.
Speakers Bureau: AstraZeneca; GSK; and Fresenius
Disclosures were obtained from the following peer reviewers and CME Outfitters, LLC, staff, with no disclosures to report:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.
Call us at 877.CME.PROS (877.263.7767).
BC-107-XXXX23-06